Skip to content
Menu

BMO Capital Maintains Market Perform on Zimmer Biomet Holdings, Lowers Price Target to $101

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

BMO Capital analyst Vik Chopra maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and lowers the price target from $102 to $101.

BMO Capital analyst Vik Chopra maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and lowers the price target from $102 to $101.

Read at benzinga.com